Mitochondrial protein S-glutathionylation: an in-depth interrogation of the glutaredoxin-2 glutathionylome and its impact on bioenergetics and redox signaling
Mitochondrial protein S-glutathionylation: an in-depth interrogation of the glutaredoxin-2 glutathionylome and its impact on bioenergetics and redox signaling
批准号:
RGPIN-2022-03240
负责人:
Mailloux, Ryan
金额:
$4.08万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-01-01 至 2023-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mitochondria are the main sources of ATP in mammalian cells and utilize hydrogen peroxide (H2O2) as a second messenger for redox signaling. H2O2 availability is budgeted carefully to elicit rapid cellular responses towards environmental cues and to avoid oxidative distress. These signals are desensitized following a burst in production by antioxidant defenses and through the inhibition of H2O2. Protein S-glutathionylation (PGLU) is a ubiquitous, reversible, and rapid redox modification that involves the site specific addition and removal of the antioxidant, reduced glutathione (GSH), to and from a proteinaceous cysteine. These reactions regulate many cellular functions and mitochondria are required to control fuel metabolism, oxidative phosphorylation, solute import, fission/fusion, and protein folding. We have discovered that PGLU serves as an important negative feedback loop for the inhibition of H2O2 production by pyruvate dehydrogenase (PDH) and a-ketoglutarate dehydrogenase (KGDH) in liver mitochondria isolated from male mice. Additionally, we found that it is required to protect from the induction of oxidative distress and is reversed by the thiol oxidoreductase glutaredoxin-2 (GRX2) following restoration of the redox buffering capacity of the GSH pool. Finally, we also discovered a novel sexual dimorphism in mitochondrial PGLU for the first time. Liver and muscle mitochondria from female mice do no require the GRX2-glutathionylome to deactivate H2O2 production by PDH and KGDH due to a superior redox buffering capacity and more efficient fuel metabolism. The long-term vision for my research program is interrogate the function of mitochondrial PGLU reactions in serving as a signaling platform to communicate changes in nutritional status and the presence of toxins to cells. However, the GRX2-glutathionylome has never been characterized and the impact of sex, an important determinant in nutritional signaling and toxin elimination, on this pathway has never been examined. This proposal aims to fill these fundamental gaps in our knowledge and further our understanding of the role of GRX2-glutathionylome signaling in mitochondrial metabolism and redox homeostasis. The overall objective of this proposal is to investigate two important lines of inquiry using an exciting platform that combines transgenic mouse models, primary cells and cultured cell lines. The first aim is to address a recent hypothesis I generated that posited PGLU is required to deactivate mitochondrial H2O2 signals. This will be studied using several cell lines knocked down for GRX2 and assessing the H2O2-mediated stimulation of adaptative signaling pathways. The second aim is to fully 1) characterize sex differences in the GRX2-glutathionylome for the first time and 2) interrogate the effect of both the loss of GRX2 and sex on mitochondrial bioenergetics and redox buffering capacity. These findings will have a significant positive impact for my long-term research vision.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.62万
-
财政年份:2021
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.62万
-
财政年份:2020
-
负责人:Mailloux, Ryan
-
依托单位:
Oroboros FluoRespirometer for the real time measurement of bioenergetics
-
批准号:RTI-2020-00380
-
项目类别:Research Tools and Instruments
-
资助金额:$7.07万
-
财政年份:2019
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.65万
-
财政年份:2019
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$0.97万
-
财政年份:2019
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.62万
-
财政年份:2018
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.62万
-
财政年份:2017
-
负责人:Mailloux, Ryan
-
依托单位:
Controlling mitochondrial bioenergetics with protein S-glutathionylation redox switches
-
批准号:RGPIN-2016-04829
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.62万
-
财政年份:2016
-
负责人:Mailloux, Ryan
-
依托单位:
国内基金
海外基金
登录
查看更多内容
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对
话促进子宫腺肌病蜕膜化缺陷的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:吕海宁
-
依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
-
批准号:32372636
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:郭慧娟
-
依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
-
批准号:82371054
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郭涛
-
依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
-
批准号:82370976
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:郑凌艳
-
依托单位:
G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
-
批准号:82370865
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:黄哲
-
依托单位:
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
-
批准号:82371660
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:魏喆
-
依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
-
批准号:82371798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:叶俊娜
-
依托单位:
紧密连接蛋白PARD3下调介导黏膜上皮屏障破坏激活STAT3/SNAI2通路促进口腔白斑病形成及进展的机制研究
-
批准号:82370954
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:沈雪敏
-
依托单位:
新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
-
批准号:82370885
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨
-
依托单位:
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
-
批准号:82371738
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:郑英霞
-
依托单位: